NTV Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.69M Sell
35,375
-162
-0.5% -$35.9K 0.85% 27
2025
Q4
$8.12M Sell
35,537
-414
-1% -$94.3K 0.86% 27
2025
Q3
$8.32M Sell
35,951
-392
-1% -$79.8K 0.91% 22
2025
Q2
$6.75M Sell
36,343
-40
-0.1% -$7.43K 0.81% 29
2025
Q1
$7.62M Sell
36,383
-1,000
-3% -$194K 1.02% 22
2024
Q4
$6.64M Sell
37,383
-436
-1% -$80.2K 0.88% 26
2024
Q3
$7.47M Sell
37,819
-682
-2% -$127K 1% 21
2024
Q2
$6.6M Buy
38,501
+302
+0.8% +$50K 0.95% 23
2024
Q1
$6.96M Buy
38,199
+376
+1% +$64.8K 1.06% 22
2023
Q4
$5.86M Sell
37,823
-5,219
-12% -$761K 0.99% 25
2023
Q3
$6.42M Buy
43,042
+70
+0.2% +$10.3K 1.16% 19
2023
Q2
$5.79M Sell
42,972
-108
-0.3% -$15.8K 1.01% 22
2023
Q1
$6.87M Buy
43,080
+134
+0.3% +$20.5K 1.28% 18
2022
Q4
$6.94M Buy
42,946
+124
+0.3% +$19K 1.36% 17
2022
Q3
$5.75M Sell
42,822
-16
-0% -$2.3K 1.21% 21
2022
Q2
$6.56M Sell
42,838
-158
-0.4% -$24.1K 1.28% 19
2022
Q1
$6.97M Buy
42,996
+22
+0.1% +$3.2K 1.17% 18
2021
Q4
$5.82M Sell
42,974
-1,176
-3% -$139K 0.97% 27
2021
Q3
$4.76M Buy
44,150
+570
+1% +$65.1K 0.83% 32
2021
Q2
$4.91M Sell
43,580
-47
-0.1% -$5.29K 0.87% 29
2021
Q1
$4.72M Buy
43,627
+428
+1% +$45.8K 0.87% 30
2020
Q4
$4.63M Buy
43,199
+253
+0.6% +$24.3K 0.93% 28
2020
Q3
$3.76M Buy
42,946
+24
+0.1% +$2.26K 0.89% 31
2020
Q2
$4.21M Buy
42,922
+3,843
+10% +$338K 1.09% 23
2020
Q1
$2.98M Buy
39,079
+2,181
+6% +$186K 0.98% 29
2019
Q4
$3.27M Sell
36,898
-68
-0.2% -$5.64K 0.83% 40
2019
Q3
$2.8M Buy
36,966
+154
+0.4% +$10.6K 0.8% 42
2019
Q2
$2.68M Buy
36,812
+10,303
+39% +$810K 0.77% 42
2019
Q1
$2.14M Buy
26,509
+454
+2% +$37.1K 0.61% 49
2018
Q4
$2.4M Sell
26,055
-798
-3% -$70.2K 0.78% 43
2018
Q3
$2.54M Sell
26,853
-497
-2% -$47.1K 0.69% 47
2018
Q2
$2.53M Buy
27,350
+52
+0.2% +$5.08K 0.71% 45
2018
Q1
$2.58M Sell
27,298
-99
-0.4% -$10.9K 0.73% 46
2017
Q4
$2.65M Sell
27,397
-373
-1% -$35.2K 0.74% 47
2017
Q3
$2.47M Sell
27,770
-5,342
-16% -$407K 0.72% 48
2017
Q2
$2.4M Buy
33,112
+103
+0.3% +$6.92K 0.73% 46
2017
Q1
$2.15M Sell
33,009
-548
-2% -$34.5K 0.68% 49
2016
Q4
$2.1M Sell
33,557
-198
-0.6% -$12.1K 0.73% 44
2016
Q3
$2.13M Sell
33,755
-148
-0.4% -$9.58K 0.77% 43
2016
Q2
$2.1M Buy
33,903
+1,222
+4% +$74.5K 0.79% 41
2016
Q1
$1.87M Buy
32,681
+402
+1% +$22.4K 0.72% 44
2015
Q4
$1.91M Sell
32,279
-3,348
-9% -$193K 0.75% 39
2015
Q3
$1.94M Buy
35,627
+2
+0% +$130 0.63% 44
2015
Q2
$2.39M Buy
35,625
+7,602
+27% +$496K 0.7% 40
2015
Q1
$1.64M Buy
28,023
+2,901
+12% +$175K 0.49% 65
2014
Q4
$1.64M Buy
25,122
+2
+0% +$126 0.49% 66
2014
Q3
$1.45M Buy
25,120
+2
+0% +$111 0.44% 72
2014
Q2
$1.42M Buy
25,118
+2,875
+13% +$151K 0.43% 72
2014
Q1
$1.14M Buy
22,243
+6,212
+39% +$314K 0.37% 80
2013
Q4
$846K Buy
16,031
+202
+1% +$9.93K 0.29% 96
2013
Q3
$708K Sell
15,829
-47
-0.3% -$2.08K 0.25% 109
2013
Q2
$656K Buy
+15,876
New +$694K 0.24% 111

Other funds holding ABBV

NTV Asset Management's ABBV Position: Q1 2026 in Review

NTV Asset Management reduced its AbbVie (ABBV) stake by 0.46% in Q1 2026, selling an estimated $35.9K and leaving 35,375 shares worth $7.69M. The position accounts for 0.85% of the portfolio, ranked #27.

NTV Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.32M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • NTV Asset Management held 35,375 shares of AbbVie worth $7.69M as of Q1 2026.
  • NTV Asset Management sold 162 AbbVie shares in Q1 2026, an estimated $35.9K.
  • AbbVie made up 0.85% of NTV Asset Management's portfolio in Q1 2026, its #27 holding.
  • NTV Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • NTV Asset Management's AbbVie position peaked at $8.32M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on NTV Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.